These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 25666294)

  • 1. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
    Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
    Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.
    Rae J; Newburger PE; Dinauer MC; Noack D; Hopkins PJ; Kuruto R; Curnutte JT
    Am J Hum Genet; 1998 Jun; 62(6):1320-31. PubMed ID: 9585602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
    Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
    Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
    Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
    Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease.
    Lin SJ; Huang YF; Chen JY; Heyworth PG; Noack D; Wang JY; Lin CY; Chiang BL; Yang CM; Liu CC; Shieh CC
    Biochim Biophys Acta; 2002 Apr; 1586(3):275-86. PubMed ID: 11997079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.
    Bustamante J; Arias AA; Vogt G; Picard C; Galicia LB; Prando C; Grant AV; Marchal CC; Hubeau M; Chapgier A; de Beaucoudrey L; Puel A; Feinberg J; Valinetz E; Jannière L; Besse C; Boland A; Brisseau JM; Blanche S; Lortholary O; Fieschi C; Emile JF; Boisson-Dupuis S; Al-Muhsen S; Woda B; Newburger PE; Condino-Neto A; Dinauer MC; Abel L; Casanova JL
    Nat Immunol; 2011 Mar; 12(3):213-21. PubMed ID: 21278736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
    Condino-Neto A; Newburger PE
    Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
    Kawai C; Yamauchi A; Kuribayashi F
    Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory diagnosis of chronic granulomatous disease].
    Zhou QH; Liu DR; Wang Y; Ying WJ; Yu YH; Wang JY; Hui XY; Sun JQ; Hou J; Wang WJ; Wang XC
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):337-43. PubMed ID: 27143074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.
    Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K
    Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.